Domain-III FG loop of the dengue virus type 2 envelope protein is important for infection of mammalian cells and Aedes aegypti mosquitoes

Virology

Volumn 406, Issue 2, 2010, Pages 328-335

  Erb, Steven M ^a   Butrapet, Siritorn ^b,c   Moss, Kelley J ^b,d   Luy, Betty E ^b   Childers, Thomas ^b   Calvert, Amanda E ^b   Silengo, Shawn J ^b,e   Roehrig, John T ^b   Huang, Claire Y H ^b   Blair, Carol D ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d UNIVERSITY OF WYOMING   (United States)

^e Inviragen Inc   (United States)

Author keywords

Dengue virus; Domain III; Envelope protein; FG loop; Flavivirus; Mosquitoes; Mutagenesis

Indexed keywords

VIRUS ENVELOPE PROTEIN;

AEDES AEGYPTI; AMINO ACID SUBSTITUTION; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENGUE VIRUS 2; FEMALE; HUMAN; HUMAN CELL; MAMMAL CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; VERO CELL; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS INFECTIVITY; VIRUS MUTANT; VIRUS MUTATION; VIRUS REPLICATION; AEDES; AMINO ACID SEQUENCE; ANIMAL; CELL LINE; CHEMISTRY; CHLOROCEBUS AETHIOPS; DENGUE; DENGUE VIRUS; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEPG2 CELL LINE; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; VERO CELL LINE; VIROLOGY;

AEDES; AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; DENGUE; DENGUE VIRUS; HEP G2 CELLS; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; VERO CELLS; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION;

AEDES AEGYPTI; DENGUE VIRUS; DENGUE VIRUS TYPE 2; FLAVIVIRUS; IXODIDA; MAMMALIA;

EID: 79953105927     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.07.024     Document Type: Article

References (60)

1. Abd-Jamil J., Cheah C.Y., AbuBakar S. Dengue virus type 2 envelope protein displayed as recombinant phage attachment protein reveals potential cell binding sites. Protein Eng. Des. Sel. 2008, 21(10):605-611.
2. Acosta E.G., Castilla V., Damonte E.B. Functional entry of dengue virus into Aedes albopictus mosquito cells is dependent on clathrin mediated endocytosis. J. Gen. Virol. 2008, 89:474-484.
3. Bhatt T.R., Crabtree M.B., Guirakhoo F., Monath T.P., Miller B.R. Growth characteristics of the chimeric Japanese encephalitis virus vaccine candidate, ChimeriVax (TM)-JE (YF/JE SAL4-14-2), in Culex tritaeniorhynchus, Aedes albopictus, and Aedes aegypti mosquitoes. Am. J. Trop. Med. Hyg. 2000, 62(4):480-484.
4. Brackney D.E., Foy B.D., Olson K.E. The effects of midgut serine proteases on dengue virus type 2 infectivity of Aedes aegypti. Am. J. Trop. Med. Hyg. 2008, 79(2):267-274.
5. Bryant J.E., Calvert A.E., Mesesan K., Crabtree M.B., Volpe K.E., Silengo S., Kinney R.M., Huang C.Y.H., Miller B.R., Roehrig J.T. Glycosylation of the dengue 2 virus E protein at N67 is critical for virus growth in vitro but not for growth in intrathoracically inoculated Aedes aegypti mosquitoes. Virology 2007, 366(2):415-423.
6. Butrapet S., Kinney R.A., Huang C.Y.H. Determining genetic stabilities of chimeric dengue vaccine candidates based on dengue 2 PDK-53 virus by sequencing and quantitative TaqMAMA. J. Virol. Methods 2006, 131(1):1-9.
7. Chen Y.P., Maguire T., Hileman R.E., Fromm J.R., Esko J.D., Linhardt R.J., Marks R.M. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat. Med. 1997, 3(8):866-871.
8. Chin J.F.L., Chu J.J.H., Ng M.L. The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entry. Microbes Infect. 2007, 9(1):1-6.
9. Chu J.J.H., Ng M.L. Infectious entry of West Nile virus occurs through a clathrin-mediated endocytic pathway. J. Virol. 2004, 78(19):10543-10555.
10. Chu J.J.H., Ng M.L. Interaction of West Nile virus with alpha(v)beta(3) integrin mediates virus entry into cells. J. Biol. Chem. 2004, 279(52):54533-54541.
11. Chu J.J.H., Rajamanonmani R., Li J., Bhuvanakantham R., Lescar J., Ng M.L. Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein. J. Gen. Virol. 2005, 86:405-412.
12. Crill W.D., Roehrig J.T. Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J. Virol. 2001, 75(16):7769-7773.
13. Gentry M.K., Henchal E.A., McCown J.M., Brandt W.E., Dalrymple J.M. Identification of distinct antigenic determinants on dengue-2 virus using monoclonal-antibodies. Am. J. Trop. Med. Hyg. 1982, 31(3):548-555.
14. Gromowski G.D., Barrett A.D.T. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus. Virology 2007, 366(2):349-360.
15. Gromowski G.D., Barrett N.D., Barrett A.D.T. Characterization of dengue virus complex-specific neutralizing epitopes on envelope protein domain III of dengue 2 virus. J. Virol. 2008, 82(17):8828-8837.
16. Gubler D.J. Dengue and dengue hemorrhagic fever. Clin. Microbiol. Rev. 1998, 11(3):480-496.
17. Guirakhoo F., Hunt A.R., Lewis J.G., Roehrig J.T. Selection and partial characterization of dengue 2 virus mutants that induce fusion at elevated pH. Virology 1993, 194(1):219-223.
18. Hahn C.S., Dalrymple J.M., Strauss J.H., Rice C.M. Comparison of the virulent asibi strain of yellow-fever virus with the 17d vaccine strain derived from it. Proc. Natl. Acad. Sci. U. S. A. 1987, 84(7):2019-2023.
19. Hase T., Summers P.L., Cohen W.H. A comparative-study of entry modes into c-6/36 cells by Semliki Forest and Japanese encephalitis viruses. Arch. Virol. 1989, 108(1-2):101-114.
20. Hase T., Summers P.L., Eckels K.H. Flavivirus entry into cultured mosquito cells and human peripheral-blood monocytes. Arch. Virol. 1989, 104(1-2):129-143.
21. Heinz F.X. Epitope mapping of flavivirus glycoproteins. Adv. Virus Res. 1986, 31:103-168.
22. Hiramatsu K., Tadano M., Men R., Lai C.J. Mutational analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence. Virology 1996, 224(2):437-445.
23. Huang C.Y.H., Butrapet S., Pierro D.J., Chang G.J.J., Hunt A.R., Bhamarapravati N., Gubler D.J., Kinney R.M. Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine. J. Virol. 2000, 74(7):3020-3028.
24. Huang C.Y.H., Butrapet S., Tsuchiya K.R., Bhamarapravati N., Gubler D.J., Kinney R.M. Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development. J. Virol. 2003, 77(21):11436-11447.
25. Huang C.Y.H., Butrapet S., Moss K.J., Childers T., Erb S.M., Calvert A.E., Silengo S.J., Kinney R.M., Blair C.D., Roehrig J.T. The dengue virus type 2 envelope protein fusion peptide is essential for membrane fusion. Virology 2010, 396(2):305-315.
26. Huerta V., Chinea G., Fleitas N., Sarría M., Sánchez J., Toledo P., Padrón G. Characterization of the interaction of domain III of the envelope protein of dengue virus with putative receptors from CHO cells. Virus Res. 2008, 137(2):225-234.
27. Hung S.-L., Lee P.-L., Chen H.-W., Chen L.-K., Kao C.-L., King C.-C. Analysis of the steps involved in dengue virus entry into host cells. Virology 1999, 257(1):156-167.
28. Hung J.J., Hsieh M.T., Young M.J., Kao C.L., King C.C., Chang W. An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells. J. Virol. 2004, 78(1):378-388.
29. Jindadamrongwech S., Thepparit C., Smith D.R. Identification of GRP 78 (BiP) as a liver cell expressed receptor element for dengue virus serotype 2. Arch. Virol. 2004, 149(5):915-927.
30. Kanai R., Kar K., Anthony K., Gould L.H., Ledizet M., Fikrig E., Marasco W.A., Koski R.A., Modis Y. Crystal structure of West Nile virus envelope glycoprotein reveals viral surface epitopes. J. Virol. 2006, 80(22):11000-11008.
31. Kinney R.M., Butrapet S., Chang G.J., Tsuchiya K.R., Roehrig J.T., Bhamarapravati N., Gubler D.J. Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53. Virology 1997, 230(2):300-308.
32. Kuhn R.J., Zhang W., Rossmann M.G., Pletnev S.V., Corver J., Lenches E., Jones C.T., Mukhopadhyay S., Chipman P.R., Strauss E.G., Baker T.S., Strauss J.H. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 2002, 108(5):717-725.
33. Lee E., Lobigs M. Substitutions at the putative receptor-binding site of an encephalitic flavivirus alter virulence and host cell tropism and reveal a role for glycosaminoglycans in entry. J. Virol. 2000, 74(19):8867-8875.
34. Lobigs M., Usha R., Nestorowicz A., Marshall I.D., Weir R.C., Dalgarno L. Host-cell selection of Murray Valley encephalitis-virus variants altered at an RGD sequence in the envelope protein and in mouse virulence. Virology 1990, 176(2):587-595.
35. Lok S.M., Kostyuchenko V., Nybakken G.E., Holdaway H.A., Battisti A.J., Sukupolvi-Petty S., Sedlak D., Fremont D.H., Chipman P.R., Roehrig J.T., Diamond M.S., Kuhn R.J., Rossmann M.G. Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins. Nat. Struct. Mol. Biol. 2008, 15(3):312-317.
36. Mandl C.W., Guirakhoo F., Holzmann H., Heinz F.X., Kunz C. Antigenic structure of the flavivirus envelope protein-e at the molecular-level, using tick-borne encephalitis-virus as a model. J. Virol. 1989, 63(2):564-571.
37. Martinez-Barragan J.D., Del Angel R.M. Identification of a putative coreceptor on Vero cells that participates in dengue 4 virus infection. J. Virol. 2001, 75(17):7818-7827.
38. McElroy K.L., Tsetsarkin K.A., Vanlandingham D.L., Higgs S. Role of the yellow fever virus structural protein genes in viral dissemination from the Aedes aegypti mosquito midgut. J. Gen. Virol. 2006, 87:2993-3001.
39. Mercado-Curiel R.F., Esquinca-Aviles H.A., Tovar R., Diaz-Badillo A., Camacho-Nuez M., Munoz M.L. The four serotypes of dengue recognize the same putative receptors in Aedes aegypti midgut and Ae. albopictus cells. BMC Microbiol. 2006, 6:10.
40. Miller J.L., deWet B.J.M., Martinez-Pomares L., Radcliffe C.M., Dwek R.A., Rudd P.M., Gordon S. The mannose receptor mediates dengue virus infection of macrophages. PLoS Pathog. 2008, 4(2):e17.
41. Modis Y., Ogata S., Clements D., Harrison S.C. A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc. Natl. Acad. Sci. U. S. A. 2003, 100(12):6986-6991.
42. Modis Y., Ogata S., Clements D., Harrison S.C. Structure of the dengue virus envelope protein after membrane fusion. Nature 2004, 427(6972):313-319.
43. Modis Y., Ogata S., Clements D., Harrison S.C. Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein. J. Virol. 2005, 79(2):1223-1231.
44. Mosso C., Galvan-Mendoza I.J., Ludert J.E., del Angel R.M. Endocytic pathway followed by dengue virus to infect the mosquito cell line C6/36 HT. Virology 2008, 378(1):193-199.
45. Navarro-Sanchez E., Altmeyer R., Amara A., Schwartz O., Fieschi F., Virelizier J.L., Arenzana-Seisdedos F., Despres P. Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO Rep. 2003, 4(7):723-728.
46. Nawa M., Machida S., Takasaki T., Kurane I. Plaque formation by Japanese encephalitis virus bound to mosquito C6/36 cells after low pH exposure on the cell surface. Jpn. J. Infect. Dis. 2007, 60(2-3):118-120.
47. Pletnev A.G., Men R. Attenuation of the Langat tick-borne flavivirus by chimerization with mosquito-borne flavivirus dengue type 4. Proc. Natl. Acad. Sci. U. S. A. 1998, 95(4):1746-1751.
48. Porollo A.A., Adamczak R., Meller J. POLYVIEW: a flexible visualization tool for structural and functional annotations of proteins. Bioinformatics 2004, 20(15):2460-2462.
49. Rey F.A., Heinz F.X., Mandl C., Kunz C., Harrison S.C. The envelope glycoprotein from tick-borne encephalitis-virus at 2angstrom resolution. Nature 1995, 375(6529):291-298.
50. Roehrig J.T., Johnson A.J., Hunt A.R., Bolin R.A., Chu M.C. Antibodies to dengue 2 virus e-glycoprotein synthetic peptides identify antigenic conformation. Virology 1990, 177(2):668-675.
51. Roehrig J.T., Bolin R.A., Kelly R.G. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. Virology 1998, 246(2):317-328.
52. Rosen L., Gubler D.J. The use of mosquitoes to detect and propagate dengue viruses. Am. J. Trop. Med. Hyg. 1974, 23(6):1153-1160.
53. Salas-Benito J., Valle J.R.D., Salas-Benito M., Ceballos-Olvera I., Mosso C., Del Angel R.M. Evidence that the 45-kD glycoprotein, part of a putative dengue virus receptor complex in the mosquito cell line c6/36, is a heat-shock-related protein. Am. J. Trop. Med. Hyg. 2007, 77(2):283-290.
54. Sukupolvi-Petty S., Austin S.K., Purtha W.E., Oliphant T., Nybakken G.E., Schlesinger J.J., Roehrig J.T., Gromowski G.D., Barrett A.D., Fremont D.H., Diamond M.S. Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes. J. Virol. 2007, 81(23):12816-12826.
55. Tassaneetrithep B., Burgess T.H., Granelli-Piperno A., Trumpfheller C., Finke J., Sun W., Eller M.A., Pattanapanyasat K., Sarasombath S., Birx D.L., Steinman R.M., Schlesinger S., Marovich M.A. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J. Exp. Med. 2003, 197(7):823-829.
56. Trirawatanapong T., Chandran B., Putnak R., Padmanabhan R. Mapping of a region of dengue virus type-2 glycoprotein required for binding by a neutralizing monoclonal-antibody. Gene 1992, 116(2):139-150.
57. Valle J.R.D., Chavez-Salinas S., Medina F., del Angel R.M. Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells. J. Virol. 2005, 79(8):4557-4567.
58. van der Most R.G., Corver J., Strauss J.H. Mutagenesis of the RGD motif in the yellow fever virus 17D envelope protein. Virology 1999, 265(1):83-95.
59. Wahala W.M.P.B., Kraus A.A., Haymore L.B., Accavitti-Loper M.A., de Silva A.M. Dengue virus neutralization by human immune sera: role of envelope protein domain III-reactive antibody. Virology 2009, 392(1):103-113.
60. Zhang Y., Zhang W., Ogata S., Clements D., Strauss J.H., Baker T.S., Kuhn R.J., Rossmann M.G. Conformational changes of the flavivirus E glycoprotein. Structure 2004, 12(9):1607-1618.